Device, Drug Import Safety Legislation Resurfaces
This article was originally published in The Gray Sheet
Executive SummaryThe House will likely consider device and drug import safety legislation in the near term, according to lawmakers and Hill staffers
You may also be interested in...
India’s Sun Pharma has been denied leave to appeal against a US court decision rejecting the company’s bid for dismissal of a multi-district antitrust lawsuit.